OXIGENE INC Files SEC form 10-Q, Quarterly Report
moreView todays social media effects on OXGNView the latest stocks trending across Twitter. Click to view dashboardSee who OXiGENE is hiring next, click here to view […]
OXGN
OXIGENE INC Files SEC form 8-K, Results of Operations and Financial Condition
moreView todays social media effects on OXGNView the latest stocks trending across Twitter. Click to view dashboardSee who OXiGENE is hiring next, click here to view […]
OXiGENE Reports First Quarter 2014 Financial Results
[GlobeNewswire] – Company Strengthens Cash Position by $20 Million moreView todays social media effects on OXGNView the latest stocks trending across Twitter. Click to view dashboardSee who OXiGENE is hiring next, click here to view […]
OXiGENE’s CEO Discusses Q4 2013 Results – Earnings Call Transcript
[at Seeking Alpha] – In 2013 we have made good progress towards our goals by significantly enhancing our cash resources, by advancing ZYBRESTAT in ovarian cancer and other cancers and by advancing our earlier stage scientific … moreView todays social media effects on OXGNView the latest stocks trending across Twitter. Click to view dashboardSee who OXiGENE is hiring next, click […]
OXIGENE INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
moreView todays social media effects on OXGNView the latest stocks trending across Twitter. Click to view dashboardSee who OXiGENE is hiring next, click here to view […]
8:57 am OXiGENE enters into definitive agreements with investors to purchase an aggregate of ~ $12 mln of units, in a registered public offering, at a price per unit of $2.05
moreView todays social media effects on OXGNView the latest stocks trending across Twitter. Click to view dashboardSee who OXiGENE is hiring next, click here to view […]
OXiGENE, Inc. Announces $12 Million Public Offering
[GlobeNewswire] – SOUTH SAN FRANCISCO, Calif. — OXiGENE, Inc. today announced that it has entered into definitive agreements with investors to purchase an aggregate of approximately $12 million of units, in a registered … moreView todays social media effects on OXGNView the latest stocks trending across Twitter. Click to view dashboardSee who OXiGENE is hiring next, click here to view […]
OXiGENE Announces Issuance of Patent for Benzosuberenes, a Novel Anticancer Class of Agents
[at noodls] – SOUTH SAN FRANCISCO, Calif., March 20, 2013 (GLOBE NEWSWIRE) — OXiGENE, Inc. (Nasdaq:OXGN), a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer, announced today that … moreView todays social media effects on OXGNView the latest stocks trending across Twitter. Click to view dashboardSee who OXiGENE is hiring next, click here to view […]
OXiGENE Announces Year-End 2012 Earnings Conference Call and Webcast
[at noodls] – SOUTH SAN FRANCISCO, Calif., March 4, 2013 (GLOBE NEWSWIRE) — OXiGENE, Inc. (Nasdaq:OXGN), a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer, will report year-end … moreView todays social media effects on OXGNView the latest stocks trending across Twitter. Click to view dashboardSee who OXiGENE is hiring next, click here to view […]
OXiGENE Announces Presentation at BIO CEO Conference on February 12th
[at noodls] – SOUTH SAN FRANCISCO, Calif., Feb. 4, 2013 (GLOBE NEWSWIRE) — OXiGENE, Inc. (Nasdaq:OXGN), a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer, announced that Peter … moreView todays social media effects on OXGNView the latest stocks trending across Twitter. Click to view dashboardSee who OXiGENE is hiring next, click here to view […]
